세계의 디지털 생물학 시장 보고서(2025년)
Digital Biology Global Market Report 2025
상품코드 : 1877604
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

디지털 생물학 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 141억 8,000만 달러에서 2025년에는 159억 7,000만 달러에 달할 것으로 추정되며, CAGR 12.6%로 성장이 전망되고 있습니다. 이 성장은 생물 정보학 도구의 도입 확대, 유전체학 및 단백질체학 연구의 진전, 생물학적 데이터를 위한 클라우드 컴퓨팅의 진화, 맞춤형 의료에 대한 수요 증가 및 생명 과학 연구에 대한 정부 자금의 확충에 의해 견인되고 있습니다.

디지털 생물학 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 259억 8,000만 달러에 달할 것으로 예측되며, CAGR 12.9%로 성장할 전망입니다. 예측 기간의 성장은 생물학 소프트웨어에 AI 및 머신러닝 통합, 합성 생물학 용도 확대, 디지털 치료제 투자 증가, 인실리코 창약 플랫폼 성장, 자동화 실험실 솔루션에 대한 수요 증가와 관련이 있습니다. 예측 기간 주요 동향에는 생물학적 시스템에 디지털 트윈 활용, 클라우드 기반 공동 조사 플랫폼, 생물학적 데이터 보안을 위한 블록체인 도입, 질병 진행 예측 모델링, 세포 프로세스 실시간 시뮬레이션 등이 있습니다.

의료 분야에서 연구개발 비용의 급증은 향후 디지털 생물학 시장의 성장에 기여할 것으로 예측됩니다. 의료 연구 개발이란 건강 상태의 개선과 환자 케어의 향상을 목적으로 하여 의료 치료법, 기기 및 절차를 창출, 검증 및 강화하기 위한 체계적인 대처를 말합니다. 의료 연구 개발비 증가는 복잡하고 새로운 건강 과제에 대응하는 신약, 의료기기 및 맞춤형 의료 솔루션의 개발에 조직이 보다 많은 자원을 배분하는 가운데 혁신적 치료법이나 선진적 치료에 대한 수요가 높아지고 있기 때문입니다. 의료 연구 개발 비용은 첨단 컴퓨팅 도구 및 바이오인포매틱스 플랫폼 구축을 지원함으로써 디지털 생물학를 지원합니다. 이들은 생물학적 데이터의 신속한 분석과 보다 정확한 질병 모델링을 가능하게 하고 진단 및 치료 개선에 기여합니다. 예를 들어, 2025년 6월에는 영국 정부 부처인 과학, 이노베이션 및 기술부가 의약품 개발을 포함한 과학 기술 연구 개발을 지원하기 위해 4년간 1,143억 8,000만 달러(860억 파운드)의 투자를 발표했습니다. 연간 지출액은 299억 3,000만 달러(225억 파운드)입니다. 그러므로 의료 분야의 연구개발 비용 급증은 디지털 생물학 시장의 성장을 지원합니다.

빅데이터 전문 서비스 시장의 주요 기업은 하이브리드 및 멀티 클라우드 인프라 전반에 걸쳐 데이터를 원활하게 통합, 관리 및 액세스할 수 있도록 데이터 패브릭 솔루션을 구축하는 것을 우선시하여 실시간 분석, 비즈니스 성능 및 데이터 중심의 의사결정을 강화하고 있습니다. 예를 들어, 2025년 9월에는 미국에 본사를 둔 소프트웨어 기업 시스코가 조직이 기계 데이터를 다루고 활용하는 방법을 변화시키고 인공지능 프로젝트를 추진하기 위해 개발된 플랫폼인 Cisco Data Fabric을 발표했습니다. 스플랑크의 지원을 받은 이 프레임워크는 엄청난 머신 데이터 관리와 관련된 비용과 복잡성을 최소화하기 위한 것입니다. 시스코 데이터 패브릭은 데이터 운영을 강화하고 AI 활용을 위한 접근성을 향상하며 대규모 데이터 세트를 처리하는 기업의 확장성 및 효율성을 높입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

The digital biology market involves the integration of computational tools, digital technologies, and advanced laboratory systems to model, simulate, and analyze biological processes at molecular, cellular, and organismal levels. By transforming biological information into digital formats, it enables precise understanding, experimentation, and innovation across various life science applications.

The major components of digital biology include software, hardware, and services. Digital biology software refers to computer programs and platforms designed to model, simulate, analyze, and interpret biological systems and processes using computational approaches. The deployment modes include on-premises and cloud, incorporating technologies such as artificial intelligence in biology, bioinformatics tools and software, blockchain for data integrity, cloud computing solutions, and deoxyribonucleic acid data storage technology. The key applications include drug discovery, agriculture, environmental monitoring, personalized medicine, synthetic biology, bioinformatics, and others. These applications are utilized by pharmaceutical and biotechnology companies, research and academic institutes, healthcare providers, contract research organizations, and government and regulatory bodies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The digital biology market research report is one of a series of new reports from The Business Research Company that provides digital biology market statistics, including digital biology industry global market size, regional shares, competitors with a digital biology market share, detailed digital biology market segments, market trends and opportunities, and any further data you may need to thrive in the digital biology industry. This digital biology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital biology market size has grown rapidly in recent years. It will grow from $14.18 billion in 2024 to $15.97 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historic period is driven by increasing adoption of bioinformatics tools, expansion of genomics and proteomics research, advancements in cloud computing for biological data, rising demand for personalized medicine, and enhanced government funding for life sciences research.

The digital biology market size is expected to see rapid growth in the next few years. It will grow to $25.98 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be connected to integration of ai and machine learning in biology software, expansion of synthetic biology applications, increasing investment in digital therapeutics, growth of in silico drug discovery platforms, and rising demand for automated laboratory solutions. Major trends in the forecast period include use of digital twins for biological systems, collaborative cloud based research platforms, adoption of blockchain for biological data security, predictive modelling for disease progression, and real time simulation of cellular processes.

The surge in healthcare research and development expenditure is expected to contribute to the growth of the digital biology market going forward. Healthcare research and development refers to the systematic efforts to create, test, and enhance medical treatments, devices, and procedures to improve health outcomes and patient care. The increase in healthcare research and development expenditure results from the growing demand for innovative treatments and advanced therapies, as organizations allocate more resources to developing new drugs, medical devices, and personalized medicine solutions that address complex and emerging health challenges. Healthcare research and development spending supports digital biology by funding the creation of advanced computational tools and bioinformatics platforms, which enable faster analysis of biological data and more accurate disease modeling to improve diagnostics and treatments. For instance, in June 2025, the Department for Science, Innovation and Technology, a United Kingdom-based government ministry, announced an investment of $114.38 billion (£86 billion) over four years to support science and technology research and development, including drug development, with annual spending of $29.93 billion (£22.5 billion). Therefore, the surge in healthcare research and development expenditure is supporting the growth of the digital biology market.

Prominent companies in the big data professional services market are prioritizing the creation of data fabric solutions to ensure smooth integration, management, and accessibility of data across hybrid and multi cloud infrastructures, thereby strengthening real time analytics, operational performance, and data driven decision making. For example, in September 2025, Cisco, a US based software enterprise, unveiled Cisco Data Fabric, a platform developed to transform how organizations handle and leverage machine data to advance artificial intelligence projects. Supported by Splunk, this framework aims to minimize expenses and complexity linked with managing vast amounts of machine data. Cisco Data Fabric enhances data operations, improves accessibility for AI utilization, and boosts scalability and efficiency for enterprises working with large scale datasets.

In January 2025, Merck, a Germany-based pharmaceutical and life sciences company, acquired HUB Organoids Holding B.V. for an undisclosed amount. The acquisition expands Merck's next-generation biology portfolio, enhancing its expertise in advanced organoid platforms and next-generation biology tools to accelerate innovation in drug discovery and personalized medicine. HUB Organoids Holding B.V. is a Netherlands-based digital biology company that specializes in developing advanced organoid platforms and next-generation in vitro models.

Major players operating in the digital biology market are Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Perkin Elmer, Agilent Technologies Inc., BGI Genomics Co. Ltd., DNAnexus Inc., Seven Bridges Genomics Inc., GenBio Inc., Evogene Ltd., Cradle B.V., Ginkgo Biosecurity, Evolutionary Scale Inc., Naturannova S.A., Nexco Analytics Inc., Latent Labs Inc., BioLizard NV, Lamin Labs Inc., LatchBio Inc., Standard BioTools Inc., Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Deep Genomics Inc., Valo Health Inc., LabGenius Ltd., Arzeda Corp., e-Therapeutics plc, Bio-Map, A-Alpha Bio Inc., Eikon Therapeutics Inc., Proscia Inc., Lifebit Biotech Ltd., Genestack Ltd., Seqera Labs SL, Sciepot, Pluto Biosciences Inc., SciNote LLC, Qlucore AB, 10x Genomics Inc., Bruker Corporation, Bio-Techne Corporation, Resolve Biosciences GmbH, RareCyte Inc., Oxford Nanopore Technologies plc, PacBio, Ultima Genomics Inc., Element Biosciences Inc., Benchling Inc., and Synthace Ltd.

North America was the largest region in the digital biology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Digital Biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital biology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital biology market consists of revenues earned by entities by providing services such as bioinformatics services, genomic sequencing and analysis, and molecular diagnostics support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital biology market also includes of sales of bioinformatics platforms, biological database subscriptions, synthetic biology design tools, laboratory automation instruments, and high-performance computing systems for biological research. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Biology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital biology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for digital biology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital biology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Digital Biology Market Characteristics

3. Digital Biology Market Trends And Strategies

4. Digital Biology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Digital Biology Growth Analysis And Strategic Analysis Framework

6. Digital Biology Market Segmentation

7. Digital Biology Market Regional And Country Analysis

8. Asia-Pacific Digital Biology Market

9. China Digital Biology Market

10. India Digital Biology Market

11. Japan Digital Biology Market

12. Australia Digital Biology Market

13. Indonesia Digital Biology Market

14. South Korea Digital Biology Market

15. Western Europe Digital Biology Market

16. UK Digital Biology Market

17. Germany Digital Biology Market

18. France Digital Biology Market

19. Italy Digital Biology Market

20. Spain Digital Biology Market

21. Eastern Europe Digital Biology Market

22. Russia Digital Biology Market

23. North America Digital Biology Market

24. USA Digital Biology Market

25. Canada Digital Biology Market

26. South America Digital Biology Market

27. Brazil Digital Biology Market

28. Middle East Digital Biology Market

29. Africa Digital Biology Market

30. Digital Biology Market Competitive Landscape And Company Profiles

31. Digital Biology Market Other Major And Innovative Companies

32. Global Digital Biology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Biology Market

34. Recent Developments In The Digital Biology Market

35. Digital Biology Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기